Agency Uncovers Problems in Drug Discount Program
By ROBERT PEAR
Published: December 1, 2005
WASHINGTON, Nov. 30 - Congressional investigators said Wednesday that they had found serious, widespread problems in a government program that issued drug discount cards to 6.4 million Medicare beneficiaries, as a precursor to the full-fledged drug benefit that takes effect next year.
The problems included inaccurate and incomplete information - disseminated by the government and insurance companies - and improper use of the discount cards to buy barbiturates and certain other drugs, explicitly forbidden by Congress.
The Bush administration had said the discount cards would cut retail prices of prescription drugs by 10 percent to 25 percent. But the investigators, from the Government Accountability Office, said Medicare officials could not document the savings because "there was a lack of reliable data" on the price concessions obtained from drug manufacturers and pharmacies.
Of the 6.4 million people who received discount cards, 1.9 million had low incomes and therefore qualified for extra assistance, up to $600 a year for each person. The administration had predicted that 4.7 million low-income people would sign up for such assistance.
The cards were issued by private entities - insurance companies and pharmacy benefit managers - known as drug card sponsors. The sponsors had contracts with the federal government, which endorsed their cards and regulated their operations. The Bush administration approved 39 national cards and 32 for specific regions....
http://www.nytimes.com/2005/12/01/politics/01medicare.html?hp&ex=1133499600&en=f7b65fe8d96d404b&ei=5094&partner=homepage